Mankind Pharma Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mankind Pharma Limited has submitted its audited financial results for the quarter and full year ended March 31, 2025 to the stock exchange. This is a routine regulatory filing under listing obligations. The detailed numbers, including revenue, profit after tax, margins, and segment performance, would be available in the accompanying results PDF. Investors should refer to the full financial statement for actual performance metrics.
This is a procedural disclosure; the actual stock and shareholder impact depends on the numbers in the full results, which the market will digest in the following trading sessions.